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Previewsanalyses are tedious work, but have paid
off in this instance by revealing a correla-
tion between the loss of BrdU-positive
nuclei and the appearance of BrdU-posi-
tive apoptotic bodies. The bulk of this
apoptosis occurs within 4 days, which
correlates well with the marker analysis,
and happens long before the migration
of the cells from the SGZ into the granular
layer. This finding is of particular interest,
given that it suggests that microglial
phagocytosis of dying newborn cells is
required to keep the extracellular milieu
of the SGZ free of secondarily necrotic
debris. The examined microglia seem to
be well suited for this role, clearing
apoptotic cells in 1.5 hr and leaving very
few un-engulfed at any given time. The
efficiency of the microglia remains unal-
tered by age or inflammatory challenge.
Sierra et al. suggest that apoptosis of
these new neurons might be a built-in
component of their mitotic program, aris-
ing from asymmetric division. If this is the
case, then it may be that the normal func-
tion of the niche is actually dependent on422 Cell Stem Cell 7, October 8, 2010 ª2010microglial phagocytosis, a previously
unappreciated facet of neurogenesis in
the SGZ.
These findings thus raise a number of
interesting conceptual issues for the study
of adult neurogenesis. Is the phagocytic
activity of ramified microglia unique to
neurogenic compartments, or is it wide-
spread throughout the brain? Sierra et al.
did not find microglia cell bodies closely
apposed to those of newborn neurons or
their progenitor cells. Is it appropriate to
think of microglia as being part of the
neurogenic niche? How are the phago-
cytic functions of these microglia related
to their recently described ability to regu-
late niche activity (Ziv et al., 2006)? How
are the microglia themselves turned
over? It is clearly necessary to expand
our knowledge of what is apparently
a complex, dynamic, and tightly integrated
relationship between adult neurogenesis
and the neuroimmune system. We look
forward to further studies that will continue
to highlight the macabre work of microglia
in regulating adult neurogenesis.Elsevier Inc.REFERENCES
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Tumor necrosis factor-a (TNF-a) has complex effects on muscle regeneration. In this issue of Cell Stem Cell,
Palacios et al. (2010) report that TNF-a-activated p38a kinase controls differentiation of muscle stem cells by
promoting polycomb repressive complex 2 (PRC2) silencing of the Pax7 promoter.Skeletal muscle growth and adaptation in
adults requires activation of resident
muscle stem cells called satellite cells.
Satellite cells are instrumental for repair
ofmuscle fibers during disease processes
such as inflammation and muscle dys-
trophy but also after excessive exercise
or unaccustomed physical activities. As
activated satellite cells proliferate and
differentiate, their chromatin architecture
undergoes changes from strongly con-
densed to more open to regulate theseprocesses. The global transition from a
condensed to an open chromatin state
involves activation of gene loci for muscle
specific transcription factors such as
MyoD and Myogenin that are silenced in
satellite cells. However, expression of
regulators critical for maintaining satellite
cells, such as Pax7, needs to be shut off
to allow differentiation to proceed. In this
issue of Cell Stem Cell, Palacios et al.
(2010) now demonstrate that the proin-
flammatory cytokine tumor necrosis fac-tor-a (TNF-a), generated during the
course of muscle regeneration by infil-
trating cells and damaged muscle fibers
(Figure 1A), signals via p38a to regulate
satellite cells. Activation of the p38a-
signaling pathway stimulates complex
formation between the PRC2 subunit
EZH2 and YY1, which leads directly to
repression of the Pax7 promoter
(Figure 1B).
Various growth factors and cytokines
(e.g., IGF-I, FGFs, NGF, HGF, BMPs,
Figure 1. Proposed Model of the Role of TNF-a/p38 Signaling during Skeletal Muscle
Differentiation and Regeneration
(A) TNF-a blockade leads to an increased number of PAX7+ satellite cells, which retain their differentiation
potential. MPC, muscle precursor cells.
(B) Role of p38aMAPK signaling in the regulation of gene expression. p38a phosphorylates and activates
the MyoD complex. p38a signaling also leads to phosphorylation of Mef2d and recruitment of the Ash2L-
containing mixed lineage leukemia (MLL) methyltransferase complex tomuscle-specific genes resulting in
H3K4 trimethylation (top). Phosphorylation of Ezh2 promotes binding to YY1 leading to elevated H3K27
trimethylation and a repressive chromatin state at the Pax7 promoter (bottom).
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PreviewsMyostatin, and TNF-a) are known to
control activation, proliferation, and differ-
entiation of satellite cells. Chronic expo-
sure to TNF-a, for example, leads to
muscle wasting (Coletti et al., 2005),
whereas blocking TNF-a signaling by
treatment with TNF-a antibodies reduces
muscle necrosis in a mouse model of
muscle dystrophy (mdx mice) and leads
to long-term benefits (Radley et al.,
2008). During the last decade, an impor-
tant role for epigenetic control of muscle
stem cell differentiation has emerged.
Actively transcribed genes are typically
hyperacetylated and have enhanced
methylation of certain lysine residues,
e.g., trimethylation of lysine-4 in histone
3 (H3K4). Other methylation states, e.g.,
H3K9 methylation and trimethylation of
H3K27 are linked to transcriptional
repression (Barski et al., 2007). It is logical
to expect that growth factors and cyto-
kines will eventually also cause changes
in the chromatin of satellite cells that shift
the balance between different epigeneticmodifications at specific gene loci. In
this issue of Cell Stem Cell, Palacios and
colleagues provides support for this
hypothesis by connecting TNFa via p38-
signaling to epigenetic control of the
Pax7 gene. The authors found that inhibi-
tionof TNF-a-signalingbyanti-TNF-aanti-
bodies in mdx mice resulted in an
increase of PAX7-positive muscle stem
cells, which retained their differentiation
potential (Figure 1A).
Further experiments revealed that the
effects of anti-TNF-a treatment on the
expansion of the stem cell pool are medi-
ated by inhibition of p38a signaling. The
p38 mitogen-activated protein kinase
(MAPK) pathway plays a critical role in
regulating gene silencing/activation and
differentiation of satellite cells. Intrigu-
ingly, different members of the p38
MAPK family have opposing effects on
satellite cell proliferation and differentia-
tion. Earlier work has suggested that
p38a is promyogenic and essential for
muscle cell differentiation. p38a-medi-Cell Stem Cellated effects involve phosphorylation of
key myogenic transcription factors such
as MyoD and Mef2d, and the chromatin
remodeling complex SWI/SNF, followed
by transcriptional activation of muscle-
specific structural genes (Simone et al.,
2004; Rampalli et al., 2007; Figure 1B,
upper panel). In contrast, phosphorylation
of MyoD by p38g results in formation of
a repressive MyoD complex and exten-
sive methylation at H3K9 (Gillespie et al.,
2009). Adding to this body of work, Pala-
cios and colleagues demonstrate that
p38a can also induce a repressive chro-
matin state. The authors show that acti-
vated p38a phosphorylates EZH2, which
enhances its association with YY1 at the
Pax7 promoter. EZH2 then trimethylates
H3K27, which confers a repressive state
to the chromatin and switches off Pax7
expression (Figure 1B, lower panel).
Apparently, PRC2 activity appears to be
a common mechanism for PAX7 repres-
sion, since it performs a similar function
on the Pax7 promoter in embryonic stem
cells (Lee et al., 2006).
The work of Palacios et al. (2010) high-
lights some intriguing aspects of the regu-
lation of Pax7 expression, which relate
also to other stem cells. The study shows
that both repressive H3K27 trimethylation
and activating H3K4 trimethylation marks
are present at the Pax7 promoter. Such
‘‘bivalent’’ domains are also found in the
chromatin of other developmentally im-
portant genes (Bernstein et al., 2006).
Moreover, YY1 and EZH2 already occupy
the Pax7 promoter in undifferentiated
myoblasts, which express PAX7 but the
association becomes stronger after phos-
phorylation of EZH2 by p38a. These find-
ings suggest that Pax7 expression is
controlled by a fine balance of PRC2
activity, regulated by p38a-dependent
phosphorylation, and an opposing H3K4
methyltransferase activity, which needs
further characterization.
The yin and yang of how the YY1/EZH2
repressor complex can balance silencing
of genes required for differentiation and
stem cell maintenance is perhaps best
understood if one looks at individual cells
and temporary states. In satellite cells, the
YY1/EZH2 complex silences genes im-
portant for muscle differentiation (Caretti
et al., 2004), but in differentiating muscle
cells it represses Pax7, which is required
for self-renewal of muscle progenitor cells
(Figure 1B). The balance between these7, October 8, 2010 ª2010 Elsevier Inc. 423
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Previewstwo activities is critically regulated by
p38a-mediated phosphorylation, which
activates myogenic genes and simulta-
neously suppresses expression of Pax7
(Figure 1B), resulting in a transition to a
differentiated state. EZH2 levels are
rapidly downregulated during muscle
differentiation (Caretti et al., 2004), so
that enhanced recruitment to certain pro-
moters after phosphorylation may be
important to enable its function. Appar-
ently, the YY1/EZH2 complex is ‘‘re-posi-
tioned’’ from genes that need to be
repressed in stem cells to genes that
need to be repressed in differentiated
cells. Precise timing would be crucial for
this system to work, which raises the
question of what mechanisms mediate
the temporal coordination of these
processes. Furthermore, the depletion of
EZH2 in differentiated myocytes leaves
open the issue how PAX7 repression is
maintained at later stages, given that424 Cell Stem Cell 7, October 8, 2010 ª2010Pax7 gene activity remains off in myonu-
clei, which are devoid of EZH2.
Detailed insight into the signaling path-
ways that control chromatin repression
and activation of crucial muscle control
genes provides new opportunities for
therapeutic manipulation of stem cell
behavior and tissue regeneration. The
pharmacological inhibition of p38a and
EZH2, which seems to promote satellite
cell expansion as demonstrated by Pala-
cios et al. (2010), are examples of such
a strategy.REFERENCES
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To control cell-type specific gene expression, transcription factors bound at distant enhancer sites need to
come into the vicinity of promoters. In a recentNature article, Kagey et al. (2010) provide evidence that Medi-
ator and Cohesin protein complexes cooperate in the formation of enhancer-promoter DNA loops.Regulation of cell-type specific gene
expression frequently involves the binding
of particular transcription factors to
enhancer sites far away from the target
promoter. In order to stimulate transcrip-
tion, the enhancer-bound activators and
the core transcription machinery bound
to the promoter site need to be brought
together, presumably through looping of
the DNA region between them. The devel-
opment of the chromosome conformation
capture (3C) technology as a method to
study the 3D arrangement of chromatin
fibers (Dekker et al., 2002) provided
evidence for the existence of such loops,
yet the molecular basis for their formation
remains unclear.It was initially believed that eukaryotic
activators or repressors interact directly
with RNA polymerase II (pol II) and the
general transcription factors at pro-
moters, in a similar manner as their prok-
aryotic counterparts. The discovery that
a coactivator complex named Mediator
was required for the activator-dependent
stimulation of pol II transcription (re-
viewed by Kornberg, 2005) suggested
that an intermediary factor had evolved
in eukaryotes, which transduces the
signals from multiple transcription factors
to the pol II holoenzyme. Because the
Mediator complex bridges enhancer-
bound transcription factors and prom-
oter-bound pol II, it is an obvious candi-date for bringing about DNA looping.
However, it was not immediately obvious
how a gigantic multi-subunit (26 compo-
nents in humans) complex that undergoes
flexible structural changes could sustain
the stable connection between two
distant chromosome sites in order to
form a loop.
Two recent studies brought a new
player into the game thatmight be respon-
sible for fastening such DNA loops. Both
studies independently revealed a link
between Mediator and Cohesin—the
chromosomal protein complex respon-
sible for sister chromatid cohesion. In a
screenaimedat identifyinggenes required
tomaintain expression of the transcription
